Chemotherapy for colorectal carcinoma: one small step forward, one step backward

Editorial

N Kemeny. J Clin Oncol. 1995 Jun.

. 1995 Jun;13(6):1287-90.

doi: 10.1200/JCO.1995.13.6.1287.

No abstract available

Comment in

Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulation.
Wadler S, Schwartz EL. Wadler S, et al. J Clin Oncol. 1995 Oct;13(10):2676-7. doi: 10.1200/JCO.1995.13.10.2676. J Clin Oncol. 1995. PMID: 7595721 No abstract available.
It is time to stratify with prognostic factors for hepatic metastases.
Petrelli NJ. Petrelli NJ. J Clin Oncol. 1995 Sep;13(9):2471-2. doi: 10.1200/JCO.1995.13.9.2471. J Clin Oncol. 1995. PMID: 7666107 No abstract available.

Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
Hill M, Norman A, Cunningham D, Findlay M, Nicolson V, Hill A, Iveson A, Evans C, Joffe J, Nicolson M, et al. Hill M, et al. J Clin Oncol. 1995 Jun;13(6):1297-302. doi: 10.1200/JCO.1995.13.6.1297. J Clin Oncol. 1995. PMID: 7751874 Clinical Trial.
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.
Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A, et al. Leichman CG, et al. J Clin Oncol. 1995 Jun;13(6):1303-11. doi: 10.1200/JCO.1995.13.6.1303. J Clin Oncol. 1995. PMID: 7751875 Clinical Trial.